{"text": "TITLE:\n      Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults\nSUMMARY:\n      The purpose of this clinical trial is to investigate the safety and tolerability of IM\n      administered CV8102 and an IM administered combination of CV8102 and rabies vaccine in\n      humans.\nELIGIBILITY CRITERIA:\n      Inclusion Criteria:\n          1. Compliant with protocol procedures and available for clinical F/U until the\n             protocol-defined end of the trial\n          2. Physical examination and laboratory results without clinically significant findings\n          3. Body Mass Index (BMI) \u2265 18.0 and \u2264 32.0 kg/m2\n          4. Subjects must use reliable forms of contraception (barrier method with spermicidal\n             agent or true abstinence) and must refrain from sperm donation during treatment and\n             the 4-week F/U period after the last treatment.\n        Exclusion Criteria:\n          1. Use of any investigational or non-registered product (adjuvant, drug) other than\n             CV8102 within 4 weeks preceding the administration of the CV8102, or planned use of\n             any such agent during the trial period\n          2. Subject has received any licensed or non-licensed vaccines within 4 weeks prior to\n             the administration of CV8102 alone or in combination with the licensed rabies vaccine\n             or planned vaccinations during the trial period\n          3. Any treatment with immunosuppressants or other immune-modifying drugs within 6 months\n             prior to the administration of CV8102 alone or in combination with the licensed\n             rabies vaccine. The use of inhaled and nasal steroids, as well as topical steroids\n             outside the vaccination area, will be permitted\n          4. Any medically diagnosed or suspected immune deficient condition based on medical\n             history and physical examination\n          5. History of autoimmune disease or suspected autoimmune disease based on medical\n             history and physical examination that cannot be ruled out based on further\n             examinations\n          6. Administration of immunoglobulins (Igs) and/or any blood products within the 3 months\n             preceding the administration of CV8102 or licensed rabies vaccine\n          7. Acute disease at the time of enrolment. Acute disease is defined as the presence of\n             any acute condition including but not limited to non-febrile or febrile common colds,\n             urinary tract infections, inflammatory, allergic or traumatic conditions that may\n             interfere with safety assessment of the investigational products\n          8. Presence or evidence of significant acute or chronic disease, in particular heart\n             disease including coronary artery disease and chronic pulmonary diseases (e.g.,\n             chronic obstructive pulmonary disease [COPD]); uncontrolled medical or psychiatric\n             illness (subjects with uncomplicated chronic diagnoses stable and treated for \u2265 3\n             months e.g., mild hypertension well-controlled with medication, may be enrolled -\n             provided the condition and its therapy are known not to be associated with an\n             immunocompromised state or an autoimmune disease)\n          9. Major congenital defects\n         10. Known allergy to any component (or closely related substance) of the licensed rabies\n             vaccine product\n         11. Known type I allergy to beta-lactam antibiotics\n         12. Evidence of current alcohol or drug abuse\n         13. History of any neurological disorders or seizures\n         14. Known seropositivity for human immunodeficiency virus (HIV), hepatitis B virus (HBV)\n             (except in subjects previously vaccinated against HBV) or hepatitis C virus (HCV)\n         15. Foreseeable non-compliance with protocol as judged by the Investigator\n         16. History of any life-threatening anaphylactic reactions\n         17. Subjects with impaired coagulation in whom an IM injection is contraindicated.\n             Additional exclusion criteria for subjects participating in the (adjuvanted) rabies\n             vaccination part:\n         18. Subject has previously received any investigational or licensed rabies vaccine\n         19. Intending to travel to regions/countries for which rabies vaccinations are\n             recommended or where high risk of infection exists according to travel\n             recommendations by the German Society of Tropical Medicine and International Health\n             (DTG) during the trial and F/U period\n         20. Subject is taking chloroquine for malaria treatment or prophylaxis.\n", "cuis": "C3811910 C3539181 C3539182 C3539954 C3539955 C3539956 C3539957 C3539959 C3539960 C3539961 C3539962 C3539963 C3539964 C3539965 C3539966 C3539967 C3539968 C3539969 C3539970 C3539971 C3539972 C3539973 C3539974 C3539975 C3539976 C3539977 C3539978 C3539979 C3540026 C3540027 C3540028 C3540030 C3540031 C3540719 C3540720 C3540721 C3540722 C3540723 C3540724 C3540740 C3854036 C0042196 C0042210 C0034494 C0439044 C1552616 C1706244 C1096775 C0034496 C3539181 C3539182 C3539954 C3539955 C3539956 C3539957 C3539959 C3539960 C3539961 C3539962 C3539963 C3539964 C3539965 C3539966 C3539967 C3539968 C3539969 C3539970 C3539971 C3539972 C3539973 C3539974 C3539975 C3539976 C3539977 C3539978 C3539979 C3540026 C3540027 C3540028 C3540030 C3540031 C3540719 C3540720 C3540721 C3540722 C3540723 C3540724 C3540740 C3854036 C3811910 C0052142 C0251244 C0965970 C0243161 C0013893 C0243161 C0025664 C0184661 C0442711 C1507394 C1522729 C2348563 C3715209 C3272565 C0442711 C1507394 C1522729 C2348563 C3715209 C0018792 C0031809 C0944752 C0946068 C0855737 C1444665 C1254595 C3694175 C0005893 C1305855 C0004764 C0558250 C0700589 C0344221 C0493327 C0877698 C0086286 C0086580 C3858758 C0037862 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C3854058 C4049936 C3843422 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C0025344 C0243161 C3245491 C1552578 C0013230 C0220825 C1261322 C0013227 C1254351 C1947944 C1514821 C0001551 C1533734 C0376495 C0199808 C0199810 C0725057 C1536282 C0001563 C0036589 C0150270 C3469597 C0025344 C0018792 C0042210 C1548573 C1533734 C0376495 C0199808 C0199810 C0725057 C1536282 C0001563 C0036589 C0150270 C3469597 C0034496 C3539181 C3539182 C3539954 C3539955 C3539956 C3539957 C3539959 C3539960 C3539961 C3539962 C3539963 C3539964 C3539965 C3539966 C3539967 C3539968 C3539969 C3539970 C3539971 C3539972 C3539973 C3539974 C3539975 C3539976 C3539977 C3539978 C3539979 C3540026 C3540027 C3540028 C3540030 C3540031 C3540719 C3540720 C3540721 C3540722 C3540723 C3540724 C3540740 C3854036 C3811910 C0052142 C0251244 C0965970 C1548573 C0042196 C2713304 C0042200 C0199810 C0025344 C0018792 C0021081 C3653856 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C0013227 C1561542 C1533734 C0376495 C0199808 C0199810 C0725057 C1536282 C0001563 C0036589 C0150270 C3469597 C3539181 C3539182 C3539954 C3539955 C3539956 C3539957 C3539959 C3539960 C3539961 C3539962 C3539963 C3539964 C3539965 C3539966 C3539967 C3539968 C3539969 C3539970 C3539971 C3539972 C3539973 C3539974 C3539975 C3539976 C3539977 C3539978 C3539979 C3540026 C3540027 C3540028 C3540030 C3540031 C3540719 C3540720 C3540721 C3540722 C3540723 C3540724 C3540740 C3854036 C3811910 C0052142 C0251244 C0965970 C1548573 C2064827 C0034496 C0004048 C0028429 C0042196 C2713304 C0058773 C0419749 C0011900 C1408353 C0012634 C3864998 C0009647 C0871117 C0021051 C0150618 C1548377 C0199200 C2148584 C0420160 C0199190 C0199202 C1548379 C0199189 C0004364 C0406632 C0400936 C0850560 C0577642 C0687719 C0262926 C2004062 C0150618 C1548377 C0199200 C2148584 C0420160 C0199190 C0199202 C1548379 C0199189 C0031809 C0582103 C0021027 C0020852 C0202081 C0020843 C0481219 C0085297 C0239984 C0850992 C0553533 C2748351 C1533734 C0725057 C0376495 C3845829 C0001563 C0036589 C0455708 C1534841 C2360550 C0456388 C1561542 C1533734 C0376495 C0199808 C0199810 C0725057 C1536282 C0001563 C0036589 C0150270 C3469597 C0034496 C1548573 C0001314 C0392148 C0009443 C0012634 C3864998 C0009647 C0871117 C0015967 C0277797 C3834249 C4049609 C4049610 C4050368 C0042029 C0262655 C2368866 C0242147 C0268821 C1279247 C1827894 C0262421 C0577708 C0749969 C0577709 C3875265 C0012634 C0442743 C0003209 C3245491 C1552578 C0013230 C0220825 C1261322 C0031809 C0870300 C1319010 C0008679 C3494714 C3266261 C0746102 C1290009 C0392148 C0018787 C0010054 C1956346 C0010068 C0024115 C0455540 C0034072 C0012634 C0018609 C0024117 C0730604 C0494659 C0730607 C0730605 C1277261 C1303174 C1272221 C0865800 C0420047 C1273971 C3714496 C3244202 C3838076 C1548428 C3526598 C0011900 C0679838 C0221423 C0424228 C0332155 C0020538 C1963138 C1696708 C2748577 C0947663 C0013227 C2081612 C2094204 C0033045 C1971835 C0802604 C2598133 C0180112 C2911690 C1561542 C0012634 C3864998 C0009647 C0871117 C0087111 C0033972 C3845898 C1555587 C0004364 C0406632 C0400936 C0850560 C0577642 C0687719 C0085393 C0744356 C3845888 C0034494 C0233492 C0445356 C0075414 C0612235 C0075371 C0253996 C0630206 C0914164 C0916881 C1524073 C1548573 C0042210 C0026458 C0020517 C0489531 C1527304 C0719113 C0719656 C3247823 C0740858 C0027765 C2015799 C0042075 C1112108 C0036572 C0262926 C2004062 C0021051 C1855166 C0043194 C0221026 C0549463 C1279481 C3714976 C0019163 C0011226 C0019159 C0019196 C0085293 C0814152 C0854496 C0019158 C0042769 C0019699 C0019196 C0011226 C0019159 C0019163 C0085293 C0814152 C0854496 C0019158 C1116171 C1519885 C0042769 C0442711 C1507394 C1522729 C2348563 C3715209 C3714738 C0376405 C3899561 C0002792 C0857035 C3161335 C0340865 C0262926 C2004062 C0441509 C1328723 C0005790 C0427579 C1561952 C0021485 C1533685 C0444600 C0021493 C1444657 C0421315 C1273094 C0243161 C0034494 C0042196 C2713304 C0058773 C0419749 C3245491 C1552578 C0013230 C0220825 C1261322 C0034496 C1548573 C0042205 C0728859 C0419723 C0419724 C0419725 C1555670 C0009450 C3714514 C0275524 C0012683 C0035637 C0276041 C0729555 C0747002 C1555670 C0013227 C3243280 C0445334 C1328956 C2718080 C0025344 C0018792 C0008269 C0055461 C0020336 C1601614 C0033107 C0199176 C3853787 C0740413 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C0024530 C0206255 C1744563 ", "concepts": "Combination, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, Vaccine, Vaccine, Rabies, Alone summary, summary clinical trial rabies vaccine, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, Combination, AP combination, MP combination, ET combination criteria, Eligibility Criteria procedures, Procedures, Protocol, Protocol, Protocol, Protocol, Protocol, Clinical Protocol, Protocol, Protocol, Protocol, Protocol, Atrial Physical examination, NOS, Eye physical examination, Eye physical examination, Physical examination normal, Physical examination status, laboratory results, no significant findings Body Mass Index, Body Mass Index barrier method, Male barrier method, contraception, IUD contraception, CAP contraception, CAP contraception, Contraception;F, Contraception;M, reliable, spermicide Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment, donation, Donation, Abstinence Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment, period Criteria investigational, investigation, investigational drug, Investigation, Investigation, drug, drug, Use, Registered, Adjuvant administration, Readministration, Dpt administration, Mmr administration, administration sets, Maladministrations, oral administration, self administration, Drug administration, drug administration period, Atrial vaccines, Licensed administration, Readministration, Dpt administration, Mmr administration, administration sets, Maladministrations, oral administration, self administration, Drug administration, drug administration, rabies vaccine, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, Combination, AP combination, MP combination, ET combination, Licensed vaccinations, Revaccinations, flu vaccinations, mmr vaccinations, period, Atrial immunosuppressants, Other immunosuppressants, Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment, drugs, month administration, Readministration, Dpt administration, Mmr administration, administration sets, Maladministrations, oral administration, self administration, Drug administration, drug administration, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, Combination, AP combination, MP combination, ET combination, Licensed topical steroids, rabies vaccine, inhaled, nasal vaccination, Revaccinations, DT vaccination, vaccination dt diagnosed, Undiagnosed, condition, Condition, conditioning, precondition, immune deficiency History and physical examination, NOS, History and physical examination, History and physical examination, camp, history and physical exam, History and physical examination, school, History and physical examination, limited, History and physical examination, license, Psychiatric history and physical examination, History and physical examination, complete autoimmune disease, autoimmune diseases skin, autoimmune disease liver, other autoimmune disease, FH: Autoimmune disease, Autoimmune disease NEC, History, History History and physical examination, NOS, History and physical examination, History and physical examination, camp, history and physical exam, History and physical examination, school, History and physical examination, limited, History and physical examination, license, Psychiatric history and physical examination, History and physical examination, complete examination, Examination immunoglobulin, g immunoglobulins, Immunoglobulin, immunoglobulin D, Immunoglobulin, IV immunoglobulin, high immunoglobulins, immunoglobulins test, low immunoglobulin, CSF immunoglobulin, Administration, Administration Set, Readministration, Administrative, Oral Administration, Self Administration, Administration type, Administration note, Administration note, blood products, month administration, Readministration, Dpt administration, Mmr administration, administration sets, Maladministrations, oral administration, self administration, Drug administration, drug administration, rabies vaccine, Licensed Acute disease, presence common colds, condition, Condition, conditioning, precondition, febrile, Afebrile, Unlimited, Unlimited, Unlimited, Unlimited Urinary tract infection NOS, Frequent urinary tract infections, urinary tract infection test, Acute urinary tract infection, Lower urinary tract infection, Genitourinary tract infection, Upper urinary tract infection, Chronic urinary tract infection, urinary tract infection e coli, urinary tract infection treated, Proteus urinary tract infection, Febrile urinary tract infection, condition, Noninflammatory, Antiinflammatory investigational, investigation, investigational drug, Assessment, assessments, Assessment, Assessment, IQ assessment chronic disease, No chronic disease, One chronic disease, chronic disease lung, chronic disease skin, Presence, heart coronary artery diseases, CAD (coronary artery disease), coronary diseases, pulmonary disease, pulmonary disease, cardiopulmonary diseases, disease, h disease chronic obstructive pulmonary disease (diagnosis), Mild chronic obstructive pulmonary disease, Other chronic obstructive pulmonary disease, Severe chronic obstructive pulmonary disease, Moderate chronic obstructive pulmonary disease, End stage chronic obstructive pulmonary disease, At risk of chronic obstructive pulmonary disease, Chronic obstructive pulmonary disease monitoring, asthma with chronic obstructive pulmonary disease, Chronic obstructive pulmonary disease screening, Chronic obstructive pulmonary disease follow-up, Chronic obstructive pulmonary disease of horses, certified chronic obstructive pulmonary disease care, chronic obstructive pulmonary disease susceptibility, Psychiatric, Psychiatric diagnoses, Misdiagnoses, illness, Stillness, untreated hypertension, Hypertension, Prehypertensions, No hypertension, hypertensin, Medications, medication:, medications:, Premedication, IV medication, Medications, Medications, controllers, Controlled, month condition, Condition, conditioning, precondition, therapy, Cotherapy, Uknown, provider autoimmune disease, autoimmune diseases skin, autoimmune disease liver, other autoimmune disease, FH: Autoimmune disease, Autoimmune disease NEC, immunocompromised Genital defects Known allergy, rabies, elated, Unrelated, substance S, substance M, substance 86, GV substance, substance 30, substance S2, substance S1, Component, Licensed vaccine product lactam antibiotics, allergy, allergy, allergy, Callergy, dallergy, Dallergy alcohol or drug abuse neurological disorders, other neurological disorders, Urological disorder, Neurological disorders NEC, seizures, History, History immunodeficiency, No immunodeficiency, Immunodeficiency 2, Immunodeficiency 1, Immunodeficiency 5s, Immunodeficiency 4, Immunodeficiency 14, Hepatitis B, hepatitis D, hepatitis, hepatitis C, hepatitis e, hepatitis g, hepatitis h, hepatitis, virus, HIV seropositivity Hepatitis C, hepatitis D, hepatitis, hepatitis B, hepatitis e, hepatitis g, hepatitis h, hepatitis, vaccinated, vaccinated, virus Protocol, Protocol, Protocol, Protocol, Protocol, Compliance, Noncompliance, Investigator CVs anaphylactic reactions, Acute anaphylactic reaction, Other anaphylactic reaction, anaphylactoid reactions, History, History Coagulation, coagulation, Coagulation, Coagulation, Coagulation, injections, injection, Reinjection, IP injection, Contraindicated, HRT contraindicated, OCP contraindicated criteria, rabies vaccination, Revaccinations, DT vaccination, vaccination dt investigational, investigation, investigational drug, Investigation, Investigation, rabies vaccine, Licensed rabies vaccinations, rabies vaccinations, 1st rabies vaccination, 2nd rabies vaccination, 3rd rabies vaccination, travel Infection, infections, Coinfections, Disinfection, RP infection, MG infection, GI infection, op infection, travel Medicine, x_Medicine, Tropica, eHealth, mHealth period, Atrial chloroquine, dichloroquine, Oxychloroquine, Cloroquine, prophylaxis, Prophylaxis, prophylaxis, TB prophylaxis, Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment, malarias, malaria, malari "}
